Disclosures for "Frequency and Severity of Neurological Symptoms Following Gluten Exposure in Individuals with Celiac Disease"
-
Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
-
Dr. Silberg has received personal compensation for serving as an employee of Beyond Celiac. Dr. Silberg has received personal compensation for serving as an employee of Finch. Dr. Silberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Ellodi. Dr. Silberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Silberg Consulting, LLC. Dr. Silberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Silberg has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ellodi. Dr. Silberg has stock in Takeda. Dr. Silberg has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Avery has received personal compensation for serving as an employee of Beyond Celiac. An immediate family member of Ms. Avery has stock in Johnson & Johnson.
-
Ms. Miller has received personal compensation for serving as an employee of Beyond Celiac. The institution of Ms. Miller has received research support from Takeda Pharmaceuticals.